Alivio Therapeutics Patents – Insights & Stats (Updated 2023)

Alivio Therapeutics has a total of 28 patents globally, out of which 6 have been granted. Of these 28 patents, more than 85% patents are active. Japan is where Alivio Therapeutics has filed the maximum number of patents, followed by Australia and USA. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Alivio Therapeutics.

Alivio Therapeutics was founded in 2016. Alivio Therapeutics is developing a novel approach to treating inflammatory illnesses by precisely modifying the immune system.

Do read about some of the most popular patents of Alivio Therapeutics which have been covered by us in this article and also you can find Alivio Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Alivio Therapeutics patent portfolio.

How many patents does Alivio Therapeutics have?

Alivio Therapeutics has a total of 28 patents globally. These patents belong to 3 unique patent families. Out of 28 patents, 24 patents are active.

How Many Patents did Alivio Therapeutics File Every Year?

Alivio Therapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantAlivio Therapeutics Applications FiledAlivio Therapeutics Patents Granted
202333
202241
202122
20201
201912
20186

How many Alivio Therapeutics patents are Alive/Dead?

Worldwide Patents

Alivio Therapeutics Patent Portfolio

How Many Patents did Alivio Therapeutics File in Different Countries?

Alivio Therapeutics Worldwide Patent Filing

Countries in which Alivio Therapeutics Filed Patents

CountryPatent
Japan7
Australia5
United States Of America4
Canada3
Europe3
Hong Kong (S.A.R.)2
Israel1

Where are Research Centers of Alivio Therapeutics Patents Located?

The Research Centers of AlivioTherapeutics Patents is the United States of America.

What Percentage of Alivio Therapeutics US Patent Applications Were Granted?

Alivio Therapeutics (Excluding its subsidiaries) has filed 4 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1 have been granted leading to a grant rate of 100%.

Below are the key stats of Alivio Therapeutics patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Alivio Therapeutics?

Law FirmTotal ApplicationsSuccess Rate
Womble Bond Dickinson Us Llp4100%

List of Alivio Therapeutics patents

Publication NumberTitle
US10881745B2Formulation Of Nanostructured Gels For Increased Agent Loading And Adhesion
US20210196836A1Formulation Of Nanostructured Gels For Increased Agent Loading And Adhesion
US20200114010A1Non-Injectable Hydrogel Formulations For Smart Release
EP3863602A1Non-Injectable Hydrogel Formulations For Smart Release
EP3773478A1Self-Assembled Gels For Controlled Delivery Of Biologics And Methods Of Making Thereof
EP3621594A1Formulation Of Nanostructured Gels For Increased Agent Loading And Adhesion
AU2021240143B2Formulation Of Nanostructured Gels For Increased Agent Loading And Adhesion
AU2019247375B2Self-Assembled Gels For Controlled Delivery Of Biologics And Methods Of Making Thereof
AU2018266131B2Formulation Of Nanostructured Gels For Increased Agent Loading And Adhesion
AU2022235578A1Self-Assembled Gels For Controlled Delivery Of Biologics And Methods Of Making Thereof
AU2019357859A1Non-Injectable Hydrogel Formulations For Smart Release
CA3113948A1Non-Injectable Hydrogel Formulations For Smart Release
CA3096745A1Self-Assembled Gels For Controlled Delivery Of Biologics And Methods Of Making Thereof
CA3061480A1Formulation Of Nanostructured Gels For Increased Agent Loading And Adhesion
JP7323608B2Non-Injectable Hydrogel Formulation For Smart Release
JP7211974B2Formulation Of Nanostructured Gels For Increased Drug Loading And Adhesion
JP2023041861A5Formulation Of Nanostructured Gels For Increased Drug Loading And Adhesion
JP2023133446ASelf-Assembling Gels And Methods For Their Production For Controlled Delivery Of Biologics
JP2023101656ANon-Injectable Hydrogel Formulations For Smart Release
JP2022103299A5Formulation Of Nanostructured Gels For Increased Drug Loading And Adhesion
JPWO2019195546A5Self-Assembled Gel For Controlled Delivery Of Biologics And Method Of Making Same
HK40065558ANon-Injectable Hydrogel Formulations For Smart Release
HK40060017ANon-Injectable Hydrogel Formulations For Smart Release
IL282061ANon-Injectable Hydrogel Formulations For Smart Release
US20190307885A1Self-Assembled Gels For Controlled Delivery Of Biologics And Methods Of Making Thereof
WO2020076453A1Non-Injectable Hydrogel Formulations For Smart Release
WO2019195546A1Self-Assembled Gels For Controlled Delivery Of Biologics And Methods Of Making Thereof
WO2018208822A1Formulation Of Nanostructured Gels For Increased Agent Loading And Adhesion

What are Alivio Therapeutics key innovation segments?

What Technologies are Covered by Alivio Therapeutics?

The chart below distributes patents filed by Alivio Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Alivio Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Alivio Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Alivio Therapeutics?

Related Articles

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.